Acute Myocardial Infarction Suppliers & Manufacturers

Founded in 2002, Jiji Biotech Co., Ltd.is a medical and health industry chain that integrates independent research and development, large-scale production and professional marketing. It has many subsidiaries and offices at home and abroad. the ...

Founded in 2000 in Germany, Translumina is a global interventional cardiovascular devices company with an ambition to deliver world-class products and services. We are a fully integrated product development and manufacturing company with ...

Response Biomedical has a global distribution network and is focused on enabling our strong network of partners to be leaders in their markets by providing exceptional levels of service and support. Response Biomedical fosters a values-based ...

MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...

Vitrosens Biotechnology is a high-tech company in Turkey founded for the development, manufacture, and delivery of in vitro diagnostic devices (IVD) to the world. Vitrosens Biotechnology headquartered in Turkey, by a group of entrepreneurs with a ...

THERMOPEUTIX, INC. is a San Diego-based privately held company that offers imaginative, innovative and economical solutions to unmet medical needs. The medical specialties that are currently targeted include interventional cardiology and radiology, ...

CeloNova BioSciences, Inc. is developer and manufacturer of a portfolio of novel surfaced coated technologies, including the proprietary Polyzene-F nanocoating. This next-generation nanocoating is the result of years of rigorous scientific research ...

NOWDiagnostics Inc., is a leader in innovative diagnostics testing. Dr. Qinwei Shi helped revolutionize lateral flow assay testing using very small sample sizes. Dr. Shi developed and perfected the platform which now is the foundation for all our ...

Polymedco is dedicated to enhancing early detection of life-threatening diseases as healthcare challenges intensify due to rising chronic disease rates, an aging population, and soaring medical costs. The company collaborates with healthcare ...

Our purpose is to improve health of the patients all around the world with our strong, hardworking, dedicated and clinically driven biomedical solutions team. Our products and technologies are mostly focused on endovascular treatment solutions with ...

Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...

Aposcience AG is a worldwide innovation leader in the field of regenerative medicine. Regenerative medicine has the potential to transform the treatment for diseases with high medical need, as the tissues afflicted by the disease process can be ...

Point of Care (PoC) medical diagnostics is a $ multi-billion global market. Driven by patient need for self monitoring and healthcare cost savings, hand-held devices or readers offering rapid diagnostic test results are fast replacing often slow and ...

Since 1986, Jant Pharmacal has supplied U.S. and international lab and diagnostic practice settings with Point of Care (POC) diagnostic tests, laboratory instrumentation, reagents and consumables. Our highly trained staff’s key focus is on our ...

UCP Biosciences, Inc. is a local headquarter of Chinese Peptide Group of Companies (CPC Group) located in the Silicon Valley, California, USA. It distributes Point-of-Care Drug Testing (POCT) devices, which are manufactured by its parent ...

XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. In the United States, coronary artery disease is a leading cause of death and disability. Our ...

Boditech Med has been established as an antibody developing and manufacturing business in 1998. We’ve changed our business direction to in-vitro diagnostic market in 2000 considering potential of the market segment. Since then, we have reached ...

We create breakthrough products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help you, your family and your community lead healthier lives, full of unlimited possibilities. Today, 109,000 of us are working ...